Mind Cure Health Inc.


Company Logo

Company Overview

Mind Cure Health Inc. is a mental health and wellness company with a mission to identify and develop products that ease suffering, increase productivity and enhance mental health.

The company’s 5 Spheres framework includes:

  • Clinical Research Technology: The company anticipates acquiring diagnostic technologies for use in clinical trials and data collection tools to help clinicians receive patient feedback to improve treatment efficacy.
  • Nootropic Formulations: The company is developing nootropic, psychoactive products and substances to promote productivity and enhanced mental health, including products launched under its MoonBeam Mushroom brand.
  • Clinical Research: The company intends to evaluate the potential for clinical trials that would benefit mental health and wellness under Health Canada’s industry-leading framework for psychedelic medicines.
  • Product Discovery: The company is evaluating the legal and commercial viability of psychedelic compounds such as psilocybin, as well as new and improved psychedelic-inspired candidates, such as non-psychoactive analogs.
  • Formulations & Supply: The company is evaluating a path to manufacture, import and supply traditional and novel pharmaceutical agents for North America to satisfy the underserved access to psychoactive compounds APIs for research.

Financial Highlights


Revenue (ttm)


Gross Profit (ttm)


Diluted EPS (ttm)

Management Team

Mr. Philip Tapley
Founder, CEO & Chairman

Mr. Michael Andrew Wolfe CA, CPA, M.B.A., MBA
Chief Financial Officer

Mr. Robert C. Hill C.A., CPA, CA, CPA
Independent Director & Corp. Sec.

Mr. Tarik Lebbadi
Chief Operating Officer

Daniel Kim
VP of Investor Relations

Mr. Daniel Herrera
Chief Growth Officer

Dr. Doron Sagman FRCPC, M.D.
Chief Medical Officer

Dr. Clare Purvis
Chief Product Officer

Sign Up for Alerts

Receive an email alert every time a company announces a merger, capital raise or files for an IPO.

Company Profile




Key Highlights

Market Capitalization

Shares Outstanding

Shares Short (% of Float)

Insider Ownership